Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer
Abstract Cytotoxic CD8+ T lymphocyte (CTL) cells are central in mediating antitumor immunity. Induction of a robust CTL response requires, CTL interaction with professional antigen-presenting cells, such as dendritic cells, displaying onco-antigenic peptide, often derived from tumor-associated antig...
Saved in:
| Main Authors: | Bansari A. Shah, James A. Holden, Jason C. Lenzo, Sara Hadjigol, Neil M. O’Brien-Simpson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-025-01118-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paving the way
by: Jean Daniélou
Published: (2024-12-01) -
Paving the way for new antimicrobial peptides through molecular de-extinction
by: Karen O Osiro, et al.
Published: (2025-02-01) -
Polymers are paving their way into defluoridation of water
by: Vipin Chandra Joshi, et al.
Published: (2023-09-01) -
Metabolomics paves the way for improved drug target identification
by: Belinda B Garana, et al.
Published: (2022-02-01) -
Paving the way to environment-friendly greener anesthesia
by: Lal Dhar Mishra, et al.
Published: (2024-01-01)